Home/ Supplements/ Niacin/ Blue Gene

Blue Gene

product on market Tablet or Pill Controlled Labs Safety: 90/100
90/100

This product looks safe

  • Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
  • 25% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

Niacin and sodium are well-studied ingredients used for metabolic support and electrolyte balance. However, the proprietary Blue C and Blue Sky complexes lack independent research, resulting in limited evidence for the overall formulation. The product maintains a high safety profile based on its current ingredient concentrations.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Blue Gene
Open Full PDF View on NIH DSLD →
Details

Label Data

5 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 mg (250% DV)
Exceeds UL by 1.4× (UL: 35 mg) 196 studies (A:5, B:63)
Sodium
41 mg (2% DV)
Blue C Complex (Combination)
3750 mg
Blue Sky Complex (Combination)
2200 mg

Other Ingredients

Maltodextrin Magnesium Stearate Artificial Colors
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take 5 tablets, once per day, 60 minutes before your workout and anytime on non-workout days. After every 2 bottles (2 months), cycle off for 2 weeks before reintroducing this supplement back into your daily routine. For best results, Blue Gene(TM) should be used in combination with other Controlled Labs products, at least 1-2 gallons of water per day, and a high protein/moderate carbohydrate diet.

Initial (First Serving Only) Instructions: To assess your individual tolerance to the formula, take 1 tablet 60 minutes before working out.

Warnings & Precautions

Keep out of the reach of children.

Do not purchase if safety seal is broken.

Warnings: You should not take this product if you have any prior medical conditions, including diabetes or high blood pressure. Consult your doctor before using this product.

Additional Information

For more details on optimizing your results, please visit: www.ControlledLabs.com

Natural Anabolic Matrix

Metadata

Product Details

DSLD Entry Date2011-11-25
Product TypeOther Combinations
FormTablet or Pill
BrandControlled Labs
DSLD ID2629
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

Rezistaf
LifeLink · Tablet or Pill
100
Coenzymated B-3 25 mg
Source Naturals · Tablet or Pill
100
Vitamin B Complex
Simply Supplements · Tablet or Pill
100
Test X180 Boost
Force Factor · Tablet or Pill
100
8-Hour Alert
MHP Maximum Human Performance · Tablet or Pill
100
View all Niacin products →
Niacin research Best Niacin All Niacin products More from Controlled Labs View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.